[
    [
        {
            "time": "",
            "original_text": "金域医学：国开博裕减持计划完成，减持股份数约922万股",
            "features": {
                "keywords": [
                    "金域医学",
                    "国开博裕",
                    "减持",
                    "922万股"
                ],
                "sentiment_score": -0.6,
                "policy_related": "false",
                "investment_strategy": "true",
                "sector_focus": [
                    "医疗",
                    "基因检测"
                ],
                "causal_factor": "true",
                "causal_impact": "negative",
                "affected_by_time_series": "true",
                "ts_effect_direction": "negative"
            },
            "scores": {
                "News_content": "金域医学：国开博裕减持计划完成，减持股份数约922万股",
                "Correlation": 10,
                "Sentiment": 4,
                "Importance": 7,
                "Impact": 6,
                "Duration": 5,
                "Entity_Density": 9,
                "Market_Scope": 3,
                "Time_Proximity": 8,
                "Headline_Structure": 7,
                "Source_Recency": 9
            }
        },
        {
            "time": "",
            "original_text": "基因测序双周榜：药明康德流通市值暴涨315亿元，核酸检测龙头金域医学“叫好不叫座”？",
            "features": {
                "keywords": [
                    "基因测序",
                    "药明康德",
                    "金域医学",
                    "核酸检测",
                    "市值暴涨",
                    "叫好不叫座"
                ],
                "sentiment_score": 0.4,
                "policy_related": "false",
                "investment_strategy": "false",
                "sector_focus": [
                    "医疗",
                    "基因检测"
                ],
                "causal_factor": "true",
                "causal_impact": "positive",
                "affected_by_time_series": "true",
                "ts_effect_direction": "positive"
            },
            "scores": {
                "News_content": "基因测序双周榜：药明康德流通市值暴涨315亿元，核酸检测龙头金域医学“叫好不叫座”？",
                "Correlation": 8,
                "Sentiment": 5,
                "Importance": 6,
                "Impact": 5,
                "Duration": 4,
                "Entity_Density": 7,
                "Market_Scope": 7,
                "Time_Proximity": 6,
                "Headline_Structure": 9,
                "Source_Recency": 7
            }
        },
        {
            "time": "",
            "original_text": "金域医学(603882.SH)股东国开博裕累计减持922.09万股 减持期限届满",
            "features": {
                "keywords": [
                    "金域医学",
                    "国开博裕",
                    "减持",
                    "922.09万股",
                    "减持期限届满"
                ],
                "sentiment_score": -0.7,
                "policy_related": "false",
                "investment_strategy": "true",
                "sector_focus": [
                    "医疗",
                    "基因检测"
                ],
                "causal_factor": "true",
                "causal_impact": "negative",
                "affected_by_time_series": "true",
                "ts_effect_direction": "negative"
            },
            "scores": {
                "News_content": "金域医学(603882.SH)股东国开博裕累计减持922.09万股 减持期限届满",
                "Correlation": 10,
                "Sentiment": 4,
                "Importance": 7,
                "Impact": 6,
                "Duration": 5,
                "Entity_Density": 10,
                "Market_Scope": 3,
                "Time_Proximity": 9,
                "Headline_Structure": 8,
                "Source_Recency": 10
            }
        },
        {
            "time": "",
            "original_text": "金域医学：股东国开博裕减持计划期限届满，累计减持1.99%股份",
            "features": {
                "keywords": [
                    "金域医学",
                    "国开博裕",
                    "减持",
                    "1.99%股份"
                ],
                "sentiment_score": -0.5,
                "policy_related": "false",
                "investment_strategy": "true",
                "sector_focus": [
                    "医疗",
                    "基因检测"
                ],
                "causal_factor": "true",
                "causal_impact": "negative",
                "affected_by_time_series": "true",
                "ts_effect_direction": "negative"
            },
            "scores": {
                "News_content": "金域医学：股东国开博裕减持计划期限届满，累计减持1.99%股份",
                "Correlation": 10,
                "Sentiment": 4,
                "Importance": 7,
                "Impact": 6,
                "Duration": 5,
                "Entity_Density": 9,
                "Market_Scope": 3,
                "Time_Proximity": 8,
                "Headline_Structure": 7,
                "Source_Recency": 9
            }
        }
    ]
]